PMDA — authorised 24 March 2014
- Marketing authorisation holder: ViiV Healthcare K.K.
- Status: approved
PMDA authorised Tivicay on 24 March 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 24 March 2014.
ViiV Healthcare K.K. holds the Japanese marketing authorisation.